To cite this paper use one of the standards below:
Please log in to watch the video
Log inBackground: An estimated 50 million people are chronically infected with hepatitis C virus (HCV). The natural history of HCV infection is based on the interaction between the virus and the host and is not fully understood. It is important to know the host factors that can modulate this progression to fibrosis, cirrhosis and hepatocellular carcinoma. Among the host factors with potential biomarkers for this progression are microRNAs (miRs). Objective: To evaluate the expression profile of miRs: hsa-miR-215-5p, hsa-miR-26b-5p, and hsa-miR-483-5p in serum samples from patients chronically infected with HCV and to associate with clinical progression. Methodology: This is a retrospective study. Forty-one patients with chronic hepatitis C were included. miRs expression profiles were associated with the stage of liver fibrosis, comparing two extremes of the disease (mild/moderate fibrosis and advanced fibrosis/cirrhosis). miR expression levels were quantified by qPCR. In addition, a complementary analysis of gene interaction networks was performed using the miRnet v 2.0 tool. Results: For miR-215-5p, we found a significant difference between patients with mild/moderate fibrosis and advanced fibrosis/cirrhosis. Regarding miR-26b-5p, we found significant data comparing viral load and response to treatment. For miR-483-5p, no associations were found. In network analysis, a total of 2,772 genes were found: 755 for miR-215-5p, 1,874 for miR-26b-5p, and 143 target genes for miR-483-5p. Only one gene (SLC26A2) was found to be common to all three miRs. miR-215-5p and miR-26b-5p were associated with HCV infection. Conclusions: This study highlights that microRNAs play a role as potential biomarkers from the natural history of HCV infection. In addition, to increase the number of the studied patients is important for a better understanding of these host factors in clinical outcomes in hepatitis C.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper